Illumina, Inc. history, company profile (overview) and corporate video
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. It is headquartered in San Diego, California, United States.
The company develops a comprehensive line of products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests.
Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments.
HISTORY
Illumina was founded as a genomics pioneer in San Diego in 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee.
In 1999, Illumina acquired Spyder Instruments for its technology of high-throughput synthesis. Spyder Instruments was founded by Michal Lebl, Richard Houghten, and Jutta Eichler).
In 2000, the company completed its Initial Public Offering.
In 2001, the company began offering single nucleotide polymorphism (SNP) genotyping services.
In 2002, the company launched its first system, the Illumina BeadLab, in 2002, using GoldenGate Genotyping technology.
In 2005, CyVera, Inc. was acquired.
In 2007, Illumina acquired the British company Solexa, Inc., founded in 1998 by Shankar Balasubramanian and David Klenerman to develop and commercialize genome-sequencing technology invented by the founders at the University of Cambridge.
In 2009, the company announced the launch of the Personal Full Genome Sequencing Service. It also acquired Avantome Inc.
In 2010, Helixis, Inc. was acquired.
In 2011, Epicentre Biotechnologies was acquired.
In 2012, BlueGnome was acquired.
In 2013, the company acquired Verinata Health, Inc., Advanced Liquid Logic, and NextBio.
In 2014, the company announced the HiSeq X Ten product. It also acquired Myraqa.
In 2015, Illumina spun off Grail, a company focused on blood testing for cancer tumors in the bloodstream. It also acquired GenoLogics Life Sciences Software Inc.
In 2016, Conexio Genomics was acquired.
In 2018, Edico Genome was acquired.
In 2020, the company acquired Enancio and BlueBee.
PRODUCTS
- Sequencing Kits
- Sequencing and Microarray Instruments
- Microarray Kits
- Clinical Research Products
- Software and Informatics Products
- Molecular Biology Reagents
- Accessory Products
PRODUCTS BY AREA OF INTEREST
- Cancer Research Products;
- Reproductive Health Products;
- Genetic & Rare Disease Products;
- Microbiology Products;
- Agrigenomics Products
- Complex Disease Products
- Drug Development Products
SERVICES
- Sequencing Services
- Microarray Services
- Proactive Instrument Monitoring
- Instrument Services & Training
With more than 10,000 employees, Illumina, Inc is considered one of the Largest Public Companies in the World, according to Forbes.
*Information from Forbes.com, Wikipedia.org, and www.illumina.com.
**Video published on YouTube by “Illumina Inc“
